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“The greatest and noblest pleasure which men can have in this world is to discover new truths; and the next is 
to shake off old prejudices” 
 
Frederick II of Prussia 
 
   3 
ABSTRACT 
Trypanosoma cruzi, a protozoan from the Kinetoplastidae family, is the etiologic agent of 
Chagas disease, a major public health problem affecting mostly the poorest areas of Latin 
America. Due to the complex nature of the parasite’s genome it has been impossible to 
produce a complete reference genome sequence, thus hampering the implementation of post-
genomic approaches to unveil the mechanisms of generation of antigenic variation and the 
identification of new drug targets. My doctoral studies have focused on the application of 
combined genome sequencing and computational methods to produce a complete reference T. 
cruzi genome sequence and perform comparative analyses to better understand the 
mechanisms that allow T. cruzi to evade the mammalian host immune system and to briskly 
adapt to novel environments. 
In paper I and II, different genome assembly strategies and second generation sequencing 
technologies were implemented to perform comparative analyses to identify elements of 
virulence between T. cruzi and two trypanosomatids that are non-pathogenic to humans: 
Trypanosoma cruzi marinkellei, a bat-restricted sub-species of the T. cruzi clade and the 
human avirulent species Trypanosoma rangeli. The studies reveal the expansion of T. cruzi-
specific genomic traits specialised in the invasion of mammalian cells. 
In paper III, using third-generation, PacBio sequencing data it was possible to assemble the 
complete reference genome sequence of a Trypanosoma cruzi isolate from the DTU-I clade. 
This breakthrough allowed us - for the first time - to explore in detail the genome architecture 
of the subtelomeric areas where many parasite virulence factors are encoded. One of the most 
interesting discoveries was the overrepresentation of interspersed retrotransposons and 
microsatellites in tandem gene arrays coding for surface molecules, hinting at a 
retrotransposon-driven mechanism of recombination for generating new sequence variants. 
Whole genome sequencing of 35 T. cruzi DTU-I isolates, collected from different locations in 
the American continent, made possible to identify and characterise the mechanisms of 
adaptability employed by the parasite. 
Finally, paper IV analyses the mechanisms of genomic hybridisation in T. cruzi and the 
evolution over time of the hybrid offspring. The analysis revealed that during hybrid 
formation, the parasite integrates genetic material from each parental strains with the aid of 
retrotransposons and microsatellites, and the genome of these hybrid isolates moves quickly 
from a tetraploid to a diploid state. As a result, the hybrid strain has more genetic material, 
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mostly in the subtelomeres, providing the parasite with a pool of new surface molecule genes 
with the potential to possibly increase its fitness in a new environment.  
In conclusion, the work presented here has advanced the understanding of parasite biology 
and provided a genomic resource to be exploited for the identification of drug targets and 
vaccine candidates. 
 
  
   5 
LIST OF SCIENTIFIC PAPERS 
I. Oscar Franzén, Carlos Talavera-López, Stephen Ochaya, Claire E. Buttler, 
Louisa A. Messenger, Michael D. Lewis, Martin S. Llewellyn, Cornelis J. 
Marinkelle, Kevin M. Tyler, Michael A. Miles, Björn Andersson. 
Comparative genomic analysis of human infective Trypanosoma cruzi 
lineages with the bat-restricted subspecies T. cruzi marinkellei. BMC 
Genomics (2012) 13:531. 
     
II. Patricia Hermes Stoco, Glauber Wagner, Carlos Talavera-López, Alexandra 
Gerber, Arnaldo Zaha, Claudia Elizabeth Thompson, Daniella Castanheira 
Bartholomeu, Débora Denardin Lückemeyer, Diana Bahia, Elgion Loreto, 
Elisa Beatriz Prestes, Fabio Mitsuo Lima, Gabriela Rodrigues-Luiz, Gustavo 
Adolfo Vallejos, José Franco da Silveira Filho, Sérgio Schenkman, Karina 
Mariante Monteiro, Kevin Morris Tyler, Luiz Gonzaga Paula de Almeida, 
Mauro Freitas Ortiz, Miguel Angel Chiurillo, Milene Höehr de Moraes, 
Oberdan de Lima Cunha, Rondon Mendoça-Neto, Rosane Silva, Santuza 
Maria Ribeiro Teixeira, Silvane Maria Fonseca Murta, Thais Cristine 
Marques Sincero, Tiago Antonio de Oliveira Mendes, Turán Peter Urmenyi, 
Viviane Grazielle Silva, Wanderson Duarte DaRocha, Björn Andersson, 
Álvaro José Romanha, Mario Steindel, Ana Tereza Ribeiro de Vasconcelos, 
Edmundo Carlos Grisard. Genome of the avirulent human-infective 
trypanosome – Trypanosoma rangeli. PLoS Neglected and Tropical 
Diseases 8(9): e3176. 
 
III. Carlos N. Talavera-López, Louisa A. Messenger, Michael D. Lewis, Juan 
D. Ramírez, Felipe Guhl, Henán Carrasco, Sofía Ocana, Jaime A. Costales, 
Edmundo C. Grisard, Daniella C. Bartholomeu, Santuza M. R. Teixeira, 
María E. Bottazzi, Peter J. Hotez, Barbara Burgleigh, Michael A. Miles, 
Björn Andersson. Genome analysis of the Trypanosoma cruzi DTU-I clade 
reveals mechanisms to generate antigenic diversity. Submitted. 
 
IV. Carlos N. Talavera-López, Michael D. Lewis, Louisa A. Messenger, 
Matthew Yeo, Michael A. Miles, Björn Andersson. Comparative genomic 
analyses of Trypanosoma cruzi experimental hybrids reveal mechanism 
of genetic exchange. Manuscript.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  6 
 
OTHER PUBLICATIONS 
 
• Björn Nystedt, Nathaniel R. Street, Anna Wetterbom, Andrea 
Zuccolo, Yao-Cheng Lin, Douglas G. Scofield, Francesco Vezzi, 
Nicolas Delhomme, Stefania Giacomello, Andrey Alexeyenko, 
Riccardo Vicedomini, Kristoffer Sahlin, Ellen Sherwood, Malin 
Elfstrand, Lydia Gramzow, Kristina Holmberg, Jimmie Hällman, 
Olivier Keech, Lisa Klasson, Maxim Koriabine, Melis Kucukoglu, 
Max Käller, Johannes Luthman, Fredrik Lysholm, Totte Niittylä, 
Åke Olson, Nemanja Rilakovic, Carol Ritland, Josep A. Rosselló, 
Juliana Sena, Thomas Svensson, Carlos Talavera-López, Günter 
Theißen, Hannele Tuominen, Kevin Vanneste, Zhi-Qiang Wu, Bo 
Zhang, Philipp Zerbe, Lars Arvestad, Rishikesh Bhalerao, Joerg 
Bohlmann, Jean Bousquet, Rosario Garcia Gil, Torgeir R. Hvidsten, 
Pieter de Jong, John MacKay, Michele Morgante, Kermit Ritland, 
Björn Sundberg, Stacey Lee Thompson, Yves Van de Peer, Björn 
Andersson, Ove Nilsson, Pär K. Ingvarsson, Joakim Lundeberg & 
Stefan Jansson. The Norway spruce genome sequence and conifer 
genome evolution. Nature (2013) 497:579 – 584. 
 
• Edmundo C. Grisard, Santuza Maria Ribeiro Teixeira, Luiz Gonzaga 
Paula de Almeida, Patricia Hermes Stoco, Alexandra Gerber, Carlos 
Talavera-López, Oberdan Cunha Lima, Björn Andersson, Ana 
Tereza Ribeiro de Vasconcelos. Trypanosoma cruzi clone Dm28c 
draft genome sequence. Genome Announcements 2(1): e1114-13.   
 
• João Luís Reis-Cunha, Gabriela F. Rodrigues-Luiz, 
Hugo O. Valdivia, Rodrigo P. Baptista, Tiago A. O. Mendes, 
Guilherme Loss de Morais, Rafael Guedes, Andrea M. Macedo, 
Caryn Bern, Robert H. Gilman, Carlos Talavera-López, 
Björn Andersson, Ana Tereza Vasconcelos and 
Daniella C. Bartholomeu. Chromosomal copy number variation 
reveals differential levels of genomic plasticity in distinct 
Trypanosoma cruzi strains. BMC Genomics (2015) 16:499. 
 
 
   7 
CONTENTS 
Chapter 1 - Introduction ....................................................................................................... 9 
 1.1 - A biologist’s field guide to genome sequencing technologies ............................. 9 
       1.1.1 - Second generation sequencing technologies: 454 and Illumina ................ 10 
       1.1.2 - Third generation sequencing: Long sequencing reads ............................... 11  
 1.2 - Introduction to genome assembly ........................................................................ 12 
       1.2.1 - Bestiarum vocabulum of sequencing data .................................................. 12 
       1.2.2 - Genome assembly algorithms .................................................................... 13 
       1.2.3 - A recipe for the perfect de novo assembly .................................................. 14 
 1.3 - Methods for comparative genomic analyses ....................................................... 15 
       1.3.1 - Alignment of sequencing reads .............................................................. 16 
       1.3.2 - Genomic variant calling in a nutshell ...................................................... 17 
 1.4 - The biology of Trypanosoma cruzi ................................................................. 19  
       1.4.1 - Life cycle ................................................................................................ 19 
       1.4.2 - Mechanisms of cellular invasion and immune evasion by T. cruzi .......... 20 
       1.4.2 - The population structure of T. cruzi ........................................................ 23 
Chapter 2 – Present Research ............................................................................................ 25 
 2.1 - Paper I and Paper II: Comparative genomics of Trypanosoma cruzi .............. 26 
 2.2 - Paper III Genome analysis of the T. cruzi TcI clade ......................................... 29 
       2.2.1 - Genome architecture ................................................................................... 29 
       2.2.2 - Mechanisms for antigenic diversity generation ......................................... 30 
       2.2.3 - The population genetics of the T. cruzi TcI clade ...................................... 32 
 2.2 - Paper IV Genome analysis of T. cruzi experimental hybrids ............................ 34 
       2.3.1 - Genome analysis of the parent strains ........................................................ 34 
       2.3.2 - Genome analysis of the hybrid strains ....................................................... 37  
Chapter 3 – Future perspectives ........................................................................................ 39 
Acknowledgements ............................................................................................................ 41 
References ........................................................................................................................... 43 
 
  
  8 
 
LIST OF ABBREVIATIONS 
SNV Single Nucleotide Variants 
CNV Copy Number Variant 
Mbp Megabasepair 
InDel Insertion/Deletion 
SV Structural Variant 
NGS Next Generation Sequencing 
IPE Illumina Paired End library 
IMP Illumina Mate Paired library 
HLA Human Leukocyte Antigen 
RNA-Seq RNA sequencing data 
RAM Random Access Memory 
PCR Polymerase Chain Reaction 
dNTP Deoxynucleotide triphosphate 
HR Homologous Recombination 
NAHR Non-allelic Homologous Recombination 
NHEJ Non-homologous End Joining 
MMEJ Microhomology-mediated End Joining 
LD Linkage Disequilibrium 
MARK Trypanosoma cruzi marinkellei 
RANG Trypanosoma rangeli 
 
 
 
 
 
 
   9 
CHAPTER 1 - INTRODUCTION 
 
1.1 A biologist’s field guide to genome sequencing technologies: 
The chain terminator sequencing method described by Frederick Sanger in 1977 1 was a 
major breakthrough that allowed molecular biologists to better understand the information 
encoded by DNA. Further technological advances, such as PCR and the incorporation of 
fluorochromes, made it possible to read the nucleotide sequence of complete genes. A gene 
sequence database was soon available for the analysis of their molecular functions and 
potential interactions, but soon it became clear that to have a complete picture of all the 
molecular processes of an organism it was necessary to go “genome-wide”.  
In the 1980’s, with the first automated sequencing machines, the idea of sequencing the entire 
human genome was proposed, and in 1988 the U.S congress funded the National Institutes of 
Health (NIH) and the Department of Energy (DoE) and in 1990 the initial research plan for 
the Human Genome Project (HGP) was released 2. The early stages of the HGP were 
dedicated to the development of new methods and technologies to analyse the genomic 
sections in a cheap and efficient way 3.    
In 1995, Haemophilus influenzae became the first organism to have its genome completely 
sequenced 4. This was later followed by the genome of other majors organisms such as 
Saccharomyces cerevisiae (1996)5, Caenorhabditis elegans (1998)6, Drosophila 
melanogaster (2000)7, and Homo sapiens (2001)8,9. The first draft genome for Trypanosoma 
cruzi was produced in 200510. These genomes were sequenced using somewhat automated 
versions of the first generation Sanger sequencing machines that produced a low amount of 
sequencing data in short time but were very expensive to maintain and involved a lot of time 
consuming manual input11. New technological advances in sequencing methods have reduced 
the operational costs while allowing a much higher level of production of data, these methods 
are usually referred as Next Generation Sequencing (NGS) technologies. The large amount of 
data produced by the second generation sequencing platforms have the shortcoming of having 
high error rates and producing significantly shorter sequence reads (35 - 150 bp) compared 
with their first generation counterparts (600 - 1000 bp) 12.    
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1.1.1 Second generation sequencing technologies: 454 and Illumina.  
The first NGS platform was the 454 pyrosequencing®. Pyrosequencing is considered a 
variant of the sequencing by synthesis (SBS) method. Genomic DNA is randomly shredded 
into small fragments of the desired size, usually ranging between 150 - 550 bp, and attached 
to a small bead where the sequencing reaction takes place. The controlled addition of dNTPs 
produce a luminous signal that is detected by a charge-couple device (CCD) camera. In this 
way, it is possible to sequentially detect which dNTP has been incorporated in the reaction 
and thus determine the nucleotide sequence 13. The reads produced by the 454 
pyrosequencing® platform ranged only between 250 - 450 bp but produced about 1 million 
reads per run which constituted a considerable advantage over the low yield Sanger 
sequencing machines 14.       
 The most widely used sequencing platform to date is the Illumina HiSeq®. Based on the 
cyclic reversible termination variant of the SBS method, the system works in a similar way as 
the Sanger sequencing technique. Following the random shredding of the genomic DNA, the 
fragments are organised into clusters and ligated to sequence adapters that serve as primers 
for a DNA polymerase reaction. This reaction is terminated once a labelled 
dideoxynucleotide triphosphate (dNTP) is incorporated into the sequence template. The 
dNTPs used in the reaction are labelled with a specific fluorochrome and these are recognised 
by a set of four lasers, each one with a specific wavelength per fluorochrome. Once the lasers 
have imaged the reaction, the labelled fluorochromes are washed away and a new sequencing 
cycle begins 15. In this way is possible to determine the nucleotide sequence of each fragment. 
The Illumina platforms produce short reads in the range of 75 - 300 bp with different 
sequencing data outputs ranging from 15 million (Illumina MiSeq®) to 6 billion (Illumina 
HiSeq X Ten®).         
454 and Illumina, were the first platforms to produce high throughput sequencing data, and 
they made it necessary to further improve the algorithms required to process and analyse the 
new kind of data. Illumina is the largest supplier of sequencing machines to date, and part of 
the success has been the ability to produce equipment tailored for specific needs such as 
bench top sequencing (Illumina MiSeq®) to population-scale whole genome sequencing 
(Illumina HiSeq X Ten®), as well as the relatively low error rate (> 0.5 %)11. This has not 
been the case for the 454 pyrosequencing® platform, where the costs of the sequencing 
reagents and the relatively low throughput compared to Illumina forced the platform to be 
officially retired in early 2016.  
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1.1.2 Third generation sequencing: Long sequencing reads: 
Second generation sequencing technologies provide researchers with large data sets that can 
be exploited for the analysis of models organisms with good reference genome sequences. 
Two examples of the application of second generation, short read sequencing in model 
organisms are the analysis of human variation in the 1000 Human Genomes Project16 and the 
ENCODE Project 17. The scenario is different for non-model organisms, as not all of them 
have been sequenced and the few that have are still not complete 18. The short length nature 
of the reads from second generation sequencing platforms makes it impossible to completely 
assemble highly repetitive regions (i.e: centromeres, telomeres, short tandem repeats, 
retrotransposons, etc) and high complexity regions (i.e: HLA loci).   
Recently, a third generation of sequencing machines have been able to produce long sequence 
reads on the order of several kilobases. One of these platforms, from Pacific Biosciences 
(PacBio), is Single-Molecule Real-Time (SMRT) sequencing. PacBio SMRT sequencing 
fixes a DNA polymerases at the bottom of a micro well known as zero-mode waveguides 19. 
The polymerase allows a single molecule of the template DNA to be processed at a time. 
Labelled dNTPs are incorporated as the DNA molecule passes the DNA polymerase, while a 
laser excites a fluorochrome and a camera detects the emitted signal. Subsequently, the 
marked dNTP is detached by the polymerase to allow the incorporation of a new nucleotide 
until the entire molecule has been processed 20. Alternatively, the process can take place in a 
circular consensus sequencing (CCS) fashion, where the single DNA molecule is circularised 
and read several times in shorter segments and the consensus of these shorter segments is 
used to produce a longer read21. The reads produced by the PacBio machines are on average 
12.5 Kb in length, but can be as long as 50 Kb 15. 
The length of these reads makes them suitable for reconstruction of complex regions in de 
novo genome assembly projects 22 or single molecule mRNA sequencing 23. Unfortunately, 
the error rate of these long reads can be as high as a 15% of the total length 24. These errors 
can be corrected using medium to high coverage (25 - 80 X) of PacBio data25 or high 
coverage (> 50 X) of Illumina data26, but the process is highly demanding in terms of 
computational resources and time-consuming; a factor that should be taken into account in 
the experimental design of a given genome project. The production of PacBio data is also 
more expensive than Illumina data with an estimate of €885 per Gb for PacBio compared to 
€133 per Gb for Illumina 15, as of 2016. 
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1.2 Introduction to genome assembly: 
Suppose for a moment that you receive a very important letter in the post and before you have 
the chance to read it, this document is thrown into a paper shredder. Twice. The task to 
assemble a genome sequence from scratch is similar to trying to put together the double-
shredded letter with the hope that you can read it and that this message makes sense. The 
process to assemble sequencing data into a complete reference genome is called de novo 
genome assembly. To date, due to technological limitations, it is not possible for any 
sequencing method to read an entire genome at once. The fact that sequencing reads are 
usually shorter than the length of an entire genome sequence implicates the need for 
algorithms to order all the reads together into a genome as if they are a jigsaw puzzle. The 
problem of genome assembly has led to multiple innovations regarding the data produced and 
the algorithms to process the data. 
Below, I give a brief description of the most popular sequencing data and assembly methods 
used to date.  
 
1.2.1 Bestiarum vocabulum of sequencing data: 
Different types of sequencing data that can be generated from second and third generation 
sequencing platforms. The generation of these data depend on the method used to build the 
sequencing library and the purpose of the sequencing experiment. 
Libraries using long genomic fragments - usually between 50 and 100 Kb - can be produced 
from a highly purified DNA preparation, as required for the PacBio sequencing protocol 15 or 
for the production of Bacterial Artificial Chromosomes (BAC), and Fosmids. The advantage 
provided by sequencing the latter relies on the distance information from the long inserts, 
which can be used for fragment ordering during a de novo assembly 27. 
Mate paired libraries, also known as jumping libraries, are produced by fragmenting DNA 
into pieces between 1 and 20 Kb in length. The long pieces of DNA are submitted to a 
circularisation process where both extremes of the DNA molecule are joined together by 
biotinylation and later sheared into smaller fragments whose ends are sequenced 28. The 
sequencing data are used to resolve long repetitive regions in de novo genome assemblies 29. 
The preparation of genome sequencing libraries with insert sizes between 180 - 1000 bp often 
starts with the enrichment of genomic material via cloning or amplification by PCR. 
   13 
However, this enrichment step is optional and it will depend on the quantity of the starting 
genomic material, as some protocols require as little as 10 ng/uL 30,31. Later, the genomic 
material is randomly sheared by means of physical (e.g: sonication), enzymatic (e.g: DNAse I 
or transposases) or chemical (e.g: metal cations) methods to the desired size 32. The resulting 
fragments are used as template for sequencing with second generation sequencing platforms. 
Two types of sequencing data can be produced with this kind of genomic library: singled and 
paired ends.   
Singled end data results from the sequencing of a fragment of one of either of the ends of a 
genomic fragment. Singled end data is currently mostly used for transcript quantification in 
RNA-Seq experiments 33.  
Paired end data is the most widely used type of sequencing data and is produced by 
sequencing both ends of a given fragment. Besides the sequence information contained in the 
reads, the data also provides distance information between both ends of the sequenced 
fragment. This information is useful for de novo genome assemblies 28 and the detection of 
genomic structural changes 34.       
 
1.2.2 Genome assembly algorithms:  
The general idea of a de novo assembly experiment is to transform the millions of short 
sequencing reads into a single consensus that contains all the information encoded by the 
genome at a high level of accuracy. To achieve this, computer scientists have implemented 
different algorithms to be able to analyse the large amount of data in an organised way to 
determine the best possible reconstruction of a genome sequence 35. 
There are two categories of algorithms used to achieve this task: Overlap Layout Consensus 
(OLC) and de Bruijn Graph (DBG). The usefulness of these algorithms depends on the type 
of sequencing data produced and the available computational resources. 
 OLC-based assemblers work the best using long sequence reads such as those produced by 
the Sanger method and PacBio. Examples of this kind of genome assembler are the CELERA 
assembler used for the first versions of the D. melanogaster and H. sapiens genome 
assemblies, among others 36. Given a set of relatively long reads, an OLC based algorithm 
will first hash the reads into smaller fragments of an arbitrary length - known as K-mers - and 
perform an all-against-all comparison of these to find overlaps. The overlaps are incorporated 
into a data structure called a graph, from where consensus sequences called contigs are 
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inferred. The nature of the algorithm, especially the all-against-all search step, makes these 
assemblers slow and impractical when working with large amounts of sequencing data 35,37; 
but recent advances have made it possible to assemble genomes to a high level of completion 
using OLC-based assemblers and long PacBio reads 25. Hybrid approaches have been 
developed to take advantage of high sequence coverage in combination with long sequences 
with limited success 38.    
DBG-based assemblers work best with short reads from second generation sequence 
platforms such as Illumina and 454. The first assembler to implement a DBG approach was 
EULER 39. The DBG algorithm relies on the lower error rate in short reads to build a graph 
based on K-mers in a similar way to OLC-based assemblers. Overlaps are stored in the graph 
and the consensus assembly results from finding the most accurate Eulerian path in the graph 
37. However, the algorithm tends to collapse repetitive sequences and to breaking the 
consensus when highly heterozygous sequences are encountered, which yields a fragmented 
assembly 29. Assemblers based on DBG are faster, but since the graph of K-mer overlaps is 
stored in the RAM of the computer, they can be computationally demanding. Despite these 
drawbacks, several implementations of DBG-based assemblers have been successfully 
applied to reconstruct the genomes of several organisms 40,41.    
The final contigs, from both approaches, will contain the best representation of the genome 
with the given sequencing data and they can be ordered into scaffolds using long insert size 
mate paired libraries 42,43, fosmid pools 27,44 and long PacBio reads 45. Additionally, the 
scaffolded genome assembly could be further improved by the incorporation of additional 
data such as optical and linkage maps 46.    
 
1.2.3 A recipe for the perfect de novo assembly:  
There are many factors involved in the successful reconstruction of a genome sequence, such 
as the presence of repetitive sequences, the level of heterozygosity, the ploidy of the 
organism, as well as the estimated genome size. Some studies have tried to benchmark the 
behaviour of different genome assemblers with different types of data from a set of species  
47,48, and although these evaluations are an invaluable resource, they do not provide an 
universal protocol for the perfect assembly. In my opinion, each genome has its own optimal 
assembly protocol that uses the techniques and algorithms available at a given time. 
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Nevertheless, thanks to the benchmarking studies, there are some parameters that can be fine-
tuned at the beginning of an assembly experiment. For example, in DBG-based assemblers, 
the first step should be the selection of the K-mer size for graph construction and for OLC-
based assemblers, the minimum overlap length between two reads. 
Most importantly, the generation of the adequate sequencing data is key for the success of the 
experiment. For an Illumina-only approach it is suggested to use at least three paired end 
libraries with insert sizes between 180 - 750 bp as well as at least three mate pair libraries 
with insert sizes between 2 - 15 Kb 29,49. With the recent introduction of third generation long 
reads, it is possible to sequence and de novo assemble small to medium genomes with a high 
level of success using these and other ordering data such as linkage and optical maps.   
Ideally, a combination of different types of data is required, but this does not guarantee an 
easy reconstruction of the genome of an organism 50. 
 
1.3 Methods for comparative genomic analyses: 
The genome sequence has been compared to a “blueprint” for life, implying that it is a rigid 
structure encoding genes for all the biological functions of an organism and without much 
change beyond point mutation in coding sequences 51. Recent studies have shown that 
genomes can be highly dynamic and that their evolution involves a wide range of genomic 
variants and adaptive evolutionary processes 52–54. The generation of de novo mutations that 
allow for sequence diversity and adaptability is closely linked to the architecture of the 
genome: retrotransposons, simple repeats, gene clusters, etc 55–59.  
The first comparative studies used protein and gene sequences to identify sequence changes 
that may produce be functional. At that time, when the number of sequences was small and 
their length was usually short, the comparisons were often performed by hand, but once the 
number of available gene sequences increased from tens to thousands, the first sequence 
alignment algorithms were implemented to perform comparative gene analyses 60,61. With the 
production of complete genome sequences and introduction of second and third generation 
sequencing platforms the field of comparative genomics was born, together with the 
difficulties of handling large amounts of sequencing data and mapping sequences with 
precision to their specific locations in genomes for comparative purposes.    
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In this section I will describe the basic methods used for comparative genomics using second 
generation sequencing data.   
 
1.3.1 Alignment of sequencing reads:  
The problem of correct placement of short reads in a genome is known as read mapping and 
there has been several implementations of methods for highly accurate mapping.   
To be able to search the genome for matches with the reads in a rapid, yet accurate way, the 
genome sequence has to be indexed. A widely used indexing strategy is based on Burrows-
Wheeler Transform (BWT), implemented in the BWA 62 and Bowtie2 63 aligners. In a BWT-
based aligner, the reads are mapped in a seed-and-extend fashion, where segments of the 
short reads - referred as seeds - are aligned against the indexed genome and the placement is 
evaluated based on the maximum number of tolerated mismatches (i.e: diversity between 
individuals of the same species). This process continues until the correct position for the 
entire read has been found, or not found, in the genome. In the case of paired end reads, the 
process is extended to both reads in a pair, and if one of the reads cannot be mapped, the 
other one could still be included in the final alignment 64. Genomic regions rich in repetitive 
sequences constitute a considerable problem for read mapping and some tools have been 
developed to map reads in these regions correctly 65. One of these tools is Stampy66, which 
uses a statistical model that takes into account not only a per-base match but also the 
surrounding area of the read to identify potential erroneous placements in repetitive regions. 
This method makes it possible to in many cases map reads in complex areas of a given 
genome and even to map sequencing data from other species with a sequence divergence up 
to 15% 65.  
To store the large amount of alignment information generated by these mappers, a new file 
format was created: The Sequence/Alignment Map or SAM 67 and its binary version BAM. 
Currently, BAM files are the standard format to store read alignment data since they are 
smaller than the human readable SAM files, but due to the rapid increase in the amount of 
sequencing data and larger, population-scale genomic studies, new versions of the format, 
such as the CRAM format used in the 1000 Human Genomes Project, have been created to 
reduce the storage footprint of large genomic datasets 16,68. 
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1.3.2 Genomic variant calling in a nutshell:      
Genomic variant calling is usually achieved by mapping reads or assembled contigs against 
the complete reference genome sequence of a given organism 69. 
The most widely used approach for variant calling is the mapping of reads from second or 
third generation sequencing platforms. Once the reads have been mapped to a reference 
sequence, the resulting mapping file has to be processed prior to variant calling. The first step 
is to sort all the alignments based on their specific coordinates in the genome. Subsequently, 
reads that are redundant, i.e: PCR and optical duplicates, are removed. Finally, labels to allow 
the identification of the sample should be added to the BAM file, e.g: sample name, 
sequencing platform, sample population, etc. Several tools have been produced to streamline 
the preprocessing of mapping files for variant calling. These include Picard Tools 70, 
SAMtools 67 and Sambamba 71. After these preprocessing steps, the mapping files are ready 
to be used for the identification of different types of genomic changes. Additional steps can 
be incorporated into the preprocessing, such as base quality recalibration, but these depend on 
the variant calling algorithm to be used and the reader is referred to the GATK Best Practices 
manual 72 for more details. After these preprocessing steps, the mapping files are ready to be 
used for the identification of different types of genomic changes. 
Several tools have been developed to use mapped reads for genomic variation analysis and, 
based on their internal algorithm, they perform better in certain genomic regions than in 
others 73–75. In my experience, a set of high quality, reliable variant calls can be obtained by 
integrating the output from multiple methods. For instance, the approach taken in the 1000 
Human Genomes Project used several variant callers and a consensus was created from all 
the results 76. In principle, variants are identified by searching for supported mismatches in 
the reads that can be linked to biology, such as sample diversity, rather than sequencing errors 
69. To achieve this, the tool used uses mapping parameters to support a statistical model to 
weight the confidence of the identified variant 77. The statistical model usually relies on how 
many bases from the mapped reads support a given variant, the sequence quality of that base, 
the mapping quality of that base, among others 78. Once the genomic variants have been 
identified, it is possible to filter more complex situations and this will depend on the purpose 
of the experiment and the genomic characteristics of the studied organism 79. 
The identified genomic variants are stored in a format called Variant Calling Format (VCF). 
This format is structured such that a given genomic change can be localised quickly in the 
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genome as well as displaying all the characteristics of the variant. Additional information, 
such as allelic frequency and genotype are also included 80.      
These genomic variants are stored in a format called Variant Calling Format (VCF). This 
format is structured in a way that a given genomic change can be localised quickly in the 
genome as well as displaying all its possible characteristic. Additional information of the 
variant in a given context such as allelic frequency and genotype are also included.     
Several tools that provide a high level of accuracy have been developed. The Genome 
Analysis ToolKit (GATK) has been developed for organisms such as human or mouse 77,81, 
but it can be adapted to work with other species 69. A different approach has been used in 
FreeBayes, where variants are identified taking both haplotypes into account directly from the 
reads 82, and a recent re-implementation has been designed for the rapid analysis of genomic 
variation in human genomes 83. An alternative approach to the study of whole genome 
variation is based on sequence or genome assembly, where instead of comparing reads 
directly, they are first assembled into contigs 84. The advantage of the assembly methods is 
that it can detect variation in regions that are not well resolved in the reference sequence, 
such as the HLA locus in the human genome, and they can be much faster than methods that 
rely on read mapping 85,86. In the future, this approach will be useful for the study of genomic 
variation in organisms with a high degree of genomic complexity.   
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1.4 The biology of Trypanosoma cruzi: 
Trypanosoma cruzi is a unicellular protozoan from the family Kinetoplastida, which contains 
other unicellular protists such as Leishmania sp., Trypanosoma brucei, Crithidia sp among 
others 87, and is the etiological agent of American trypanosomiasis, clinically known as 
Chagas disease 88. The disease and the parasite were first described by Carlos Chagas in 1907 
while he was working as a medical doctor for a malaria eradication program in the Brazilian 
state of Minas Gerais 89. It is estimated that there are 6 - 7 million people infected with T. 
cruzi just in Latin America90 but with many more at risk, particularly in the poorest regions 91.  
In this section I will provide a very brief introduction to the biology of T. cruzi and its clinical 
features.  
1.4.1 T. cruzi life cycle:  
Trypanosoma cruzi has a complex, dual life cycle with four main stages 92,93. As an 
epimastigote, the parasite has the ability to survive in the insect intestine without causing any 
detectable pathology. In this stage, T. cruzi undergoes binary fission. When the parasite exits 
the gut in the vector feces, it transforms into metacyclic trypomastigotes. The vector takes a 
bloodmeal from the mammalian host by perforating the skin with its proboscide and locally 
anesthetizes the perforated area with its saliva. Once the vector finishes the meal, it deposits 
fecal material near the wound area. When the parasite exits the gut in the vector feces, it 
transforms into metacyclic trypomastigotes. After the anesthetizing effect expires the host 
auto-inoculates the metacyclic trypomastigotes through skin abrasions at the bite site or other 
mucosas. When the metacyclic trypomastigotes enter the bloodstream, they transform into the 
slender trypomastigote form that evades the host immune system and invades host cells, with 
a preference for myocytes 94. Once the parasite is inside the target cell, it transforms into a 
rounded form called amastigote, which proliferates quickly inside the host cell forming 
clusters which disrupt the cell membrane, followed by transformation of the parasites into 
trypomastigotes that can infect other cells or be ingested by another vector to continue the life 
cycle 95,96.     
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Figure 1: Trypanosoma cruzi life cycle. Image credit: Bern C. (2015) Chagas’ disease. N Engl J Med 373:456 - 
466. 
 
1.4.2 Mechanisms of cellular invasion and immune evasion by T. cruzi: 
Trypanosoma cruzi establishes chronic infection by successful evasion of the innate and 
adaptive immune responses, a strategy shared with other kinetoplastids. However, instead of 
entering the phagocytic immune cells, as is the case for Leishmania sp., T. cruzi invades other 
nucleated cells 97,98. 
The complement pathway and its serum components is the most important innate immune 
response challenge for T. cruzi 99,100. Antigenic molecules present on the surface of the 
parasite trigger the proteolytic cleavage of C3, resulting in C3b molecules that attach to the 
parasite surface antigens and promote the accumulation of the complement elements involved 
in pathogen cellular lysis 99,101. To avoid being lysed by the complement pathway, T. cruzi 
releases trans-sialidases and mucins that specifically attach to C3a and C3b and block them. 
After T. cruzi penetrates the skin or mucosa, it invades non-professional phagocytic cells by 
attaching itself using surface molecules, such as trans-sialidases and mucins 102. Once 
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attached, T. cruzi can be internalised into the cell by two mechanisms: Ca++-dependent 
lysosomal recruitment at the parasite entry site 103, a pathway shown to be used by isolates 
from the TcI clade; or parasite infolding into the plasma membrane with followed by 
lysosomal fusion, a pathway favored by isolates from the TcII - TcVI clades 94,104,105. To date, 
it is not known if the parasite exploits a specific host cell receptor to promote the 
internalisation 104.  
Lysosomes attached to the vacuole containing the parasite and the low pH environment - 
produced by oxidative radicals - facilitates the transition of the trypomastigote to the 
amastigote 106,107. Inside the acidic phagolysosome, the parasite releases trans-sialidases that 
remove the sialic acid from lysosome-associated membrane proteins (LAMP1 and LAMP2), 
which appear to act as structural scaffolds for the phagolysosome 108,109. Additionally, the 
parasite also releases pore-forming proteins that allow the parasite to escape to the cytosol, 
where the trypomastigote transforms into an amastigote and proliferates inside the cell 110. 
After a variable number of replications, the amastigotes convert to trypomastigotes that 
disrupt the cellular membrane and are released to the bloodstream, ready to invade new cells.  
The intracellular stage of the parasite protects itself from the host innate immune response by 
hijacking cellular signalling pathways and reshaping the cellular structure 101, but the viability 
of Trypanosoma cruzi inside the host depends on its ability to evade the innate and adaptive 
immune systems. It is possible to detect different sequence variants of surface molecules 
involved in immune evasion between metacyclic trypomastigotes and amastigotes 111. 
This ability has been linked to specific gene families, most of them coding for surface 
molecules 112. These molecules have been identified by studying the behaviour of the parasite 
in different culture conditions and other modified environments 113,114. Two of the first gene 
families to be associated with virulence were trans-sialidases 115 and mucins 116.  
Trans-sialidases were first described in T. cruzi in as a modified version of a sialidase enzyme 
involved in the incorporation of sialic acid on the parasite cellular surface 117. Since T. cruzi is 
not able to synthesize sialic acid de novo, it is taken from the surface of host cells and 
transferred to acceptor molecules located on the parasite surface 118.  
It has been estimated that the reference T. cruzi TcVI CL Brener strain contains about 1400 
genes that code for trans-sialidase family members 119. Based on a sequence clustering 
analysis, it was concluded from the sequence diversity of these genes that they split into four 
different groups with individual expression patterns and specific chromosomal locations 120. 
Members of the trans-sialidases gene family are actively involved in the cell invasion 
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process, where they participate in the cell adhesion process, thus facilitating the entry of the 
parasite into a specific host cell. Additionally, it has been observed that T. cruzi sheds trans-
sialidases to the bloodstream as a way to modify the surface of target cells to facilitate 
invasion 121. Trans-sialidases play a fundamental role in parasite immune evasion by 
suppressing the triggering of the complement pathway. Early studies demonstrated that the 
removal of sialic acid attached to the parasite surface made it more vulnerable to the host 
complement system and phagocytosis 122. A specific group of trans-sialidases genes, 
described as Complement Regulatory Proteins (CRP), binds to the complement elements C3b 
and C4b and prevents them from recognizing the parasite 97,123. Trans-sialidases may also 
influence the regulation of T-cells by modifying the sialylation of the cell surface and 
preventing the activation of these cells against T. cruzi 118. It has also been shown that trans-
sialidases can re-sialylate the surface of CD8+ T-cells, and thereby hampering the response of 
these cells to the parasite invasion 124. These characteristics, despite the variability, could 
make trans-sialidases suitable for immunotherapy development and possibly targets for 
testing new enzymatic inhibitors. More studies are required to understand the complete 
interaction with the host immune system and the mechanisms involved in the generation of 
sequence diversity in members of this gene family.         
Mucins are heavy glycoproteins that can be found covering epithelial cells of the digestive 
and respiratory tract of mammals 125. They are also found in the surface membrane of T. cruzi 
and other protozoans as acceptors of sialic acid. In this way a negatively-charged sugar coat is 
formed as a means to evade the immune response of the host and the vector 126,127. This gene 
family, with approximately 900 gene copies 10,119, is one of the most diverse in the T. cruzi 
genome and the genes are variable in sequence 116 and structure between isolates 127.  
The TcMUC mucins are expressed in the mammalian host while TcSMUG mucins are 
expressed in the vector and both are post-translationally modified in a different way 128. 
Previous studies have shown that mucins have an important role in parasite immune evasion 
by stimulating dendritic cells via TLR2, and this activation has been found to delay the rapid 
response of other elements of the immune system, such as CD8+ T-cells 129. A novel gene 
family, Mucin-associated surface proteins, was identified after the first draft genome 
sequence was published. These genes comprise 6% of the CL Brener genome and are found 
near Mucin tandem gene arrays and they are expressed during the trypomastigote stage 130, 
which makes them possible vaccine candidates 131. The expression patterns of MASPs in the 
trypomastigote have been observed to be tissue-specific, and they seem to be more actively 
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expressed when the parasite is in the bloodstream, compared with other host locations, 
suggesting a differential expression mechanism linked to the surrounding environment 132,133.          
Protozoan genes coding for specific molecules, such as mucins with 
glycosilphosphatidylinositol (GPI) anchors, are recognised by the innate system via Toll-like 
receptors (TLR) and promote the activation of innate effectors like macrophages and 
dendritic cells 97,134. After the GPI-anchored molecule is recognised by TLR4 or TLR2, 
members of the mitogen-activated protein kinase (MAPK) and nuclear factor kB (NF-kB) are 
activated and trigger the release of IL-12, TNF and INF-  129,134. Other receptors, such as 
TLR-9 can trigger the same response by recognition of nucleic acids 135. T. cruzi use innate 
immune response pathways, specifically TLR-2 and TLR-4, to establish chronic infection. 
One example is the induction of protein phosphatase 2A by T. cruzi, which leads to the 
deactivation of MAPK and NF-kB molecules, thus promoting immune tolerance to secondary 
exposure 136.  
The slow initial response of the host cellular immunity is the direct result of the evasion of 
innate immunity by T. cruzi 98,137. The adaptive immune response is triggered by cell death 
after the parasite has disrupted the cellular membrane, which results in a strong, CD8+-
mediated immune response which targets the antigens exposed on the parasite surface at the 
late amastigote and early trypomastigote stages 138. However, this parasitic antigenic coat is 
very variable and by the time the adaptive immune response has been mounted to target these 
antigens, a new antigenic combination of trans-sialidases and mucins is expressed on the 
parasite surface 139. 
 
1.4.1 The population structure of T. cruzi:  
Early studies using a set of biochemical 140 and molecular 141 markers indicated that T. cruzi 
has an exclusively clonal population structure 142. This clonal theory is based on using 
different sets of markers that show a clonal behaviour based on population genetic tests, such 
as high levels of linkage disequilibrium (LD), the presence of ‘near clades’ and 
overrepresentation of multilocus genotypes 143. Analyses of genetic signatures in the 
kinetoplast minicircle (kDNA) indicated that these clonal groups had a single origin, thus 
reinforcing the clonal model for T. cruzi 144. Later meta-analyses using additional markers 
such as isoezymes, Random Amplified Polymorphic DNA (RAPD), microsatellites, among 
others identified signatures of long-term clonal evolution and the clustering of the current 
strains into subgroups denominated as Discrete Typing Units (DTUs)145. Further 
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characterisation using a wide panel of markers in selected reference isolates established the 
subdivision of T. cruzi into six DTUs 146,147. These clonal DTUs have been observed to have 
different patterns of virulence and tissue tropism in the mammalian host 148. 
 
However, these observations were challenged when genetic interchange to produce hybrid 
strains was demonstrated 149,150. Analyses of different nuclear and mitochondrial markers 
have demonstrated that hybridisation events have occurred 151 and that these hybridisation 
events have created three major groups 10,152. Moreover, active genetic exchange in field 
isolates have also been demonstrated using nuclear and mitochondrial markers 153. Population 
genetic studies of isolates derived from humans, indicated the existence of natural hybrids 
and strain variability linked to anthroponotic dispersal 154. Furthermore, evidence of 
mitochondrial introgression has been observed in field and in vitro isolates 155. 
 
As a response to this challenging observations, the clonal model was further developed into 
the Predominant Clonal Evolution (PCE) model 156,157, which states that despite the 
observation of genetic exchange in Trypanosoma cruzi, and other parasites, the exchange is 
rare and the main model of propagation is clonal, with random cases of selfing and 
parthenogenesis 158. Thus far, the population genetics analyses of field isolates does not agree 
with this model 159, and large studies have confirmed that there is more divergence within a 
single DTU than what would be expected under a clonal model 160. 
To date, the population structure of T. cruzi is far from completely understood.    
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CHAPTER 2 – PRESENT RESEARCH 
 
2.1 Paper I and Paper II: Comparative genomics of Trypanosoma cruzi: 
Insights into mechanisms of virulence from other trypanosomatids.  
 
The first draft genome assembly for Trypanosoma cruzi was produced using first-generation, 
Sanger sequencing data 10 and was used to performed the first comparative analysis with the 
other kinetoplastid species Trypanosoma brucei and Leishmania major 161. This first 
assembly provided an adequate reconstruction of the core regions where the housekeeping 
genes are located, despite a high degree of polymorphism in the CL Brener reference strain, 
but the highly repetitive subtelomeric regions, where most of the surface molecule gene 
families are encoded, were only partially assembled and highly fragmented 162,163. In paper I 
and paper II we sequenced and assembled a less polymorphic TcI strain of T. cruzi from 
high sequence coverage of different types of second-generation reads, and compared this 
genome against two kinetoplastids that do not cause disease in the human host: Trypanosoma 
cruzi marinkellei (MARK) which is restricted to bats 164 and Trypanosoma rangeli (RANG) 
which is highly prevalent in opossums but also common in humans 165. 
In paper I we used high coverage of Illumina and 454 short reads and a hybrid assembly 
approach to reconstruct the genome sequence of T. cruzi TcI Sylvio X10/cl1 and MARK and 
performed comparative analyses. This strategy made use of the assemblers developed for 
early second-generation sequencing technologies with reads ranging between 50 - 75 
nucleotides (nt) in length, such as the Velvet assembler 166; and the Celera assembler for the, 
relatively, long (~ 350 nt) 454 reads 167. Since genome assemblers perform better in different 
genomic regions and with different datasets 168, merging the individual assemblies produced a 
more contiguous and correct de novo draft sequence for these parasite genomes. This resulted 
in improved assemblies, producing the most contiguous T. cruzi genome sequence yet, when 
compared with previous attempts using only 454 short reads 169. This new assembly made it 
possible to perform intra-species comparative genomics for the first time. The initial analysis 
revealed that the two sub-species displayed a coding sequence divergence of nearly 7.5 % 
and MARK was found to have a smaller genome compared to Sylvio X10/cl1. Both 
protozoans shared the same core genome components but the Sylvio X10/cl1 genome has 
more genes coding for surface protein families involved in infection and possible host 
specificity (See paper III).   
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In paper II high coverage of 454 paired end data was used to assemble the genome of T. 
rangeli. The lower repeat content of RANG made it possible to reconstruct the complete 
genome using the 454 short reads, which combined with the linking information produced 
long scaffolds. This would not have been possible for a more complex genome, where only 
this type of sequencing data is not enough to produce such contiguity 167,168. We could 
assemble the complete genome of RANG into only 259 scaffolds with an average length of ?, 
with an mean scaffold size of 202 kilobases. The low repetitive content of RANG allowed the 
genome assembler to reconstruct the complete genome using the 454 short reads, which 
combined with the linking information produce long scaffolds; unlike more complex 
genomes where these sequencing data is not enough to produce such contiguity 170,171. A 
drastic reduction in the copy numbers of surface molecule gene families was observed when 
compared with the T. cruzi CL Brener strain. The reduction of genes such as trans-sialidases 
and mucins could indicate an adaptive evolution process by genome reduction 59,172, and it 
can be speculated that the absence of these genes could be involved in the inability of RANG 
to cause disease in mammals 173. The levels of simple repeats in RANG were much lower 
than those observed in Sylvio X10/cl1 (See paper III), but the overall reduction of genome 
size seems to be almost entirely related to the contraction of repetitive gene families, which is 
in line with selection to reduce paralog content to redirect resources to other biochemical 
pathways that may confer an adaptive advantage 174. On the other hand, the large numbers of 
members of these gene families in T. cruzi could indicate their importance for the the 
invasion of particular cells and tissues 175.     
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Figure 2: Structure of T. rangeli telomeres showing reduction of surface molecule gene families in comparison 
with T. cruzi and T. brucei. (See paper II). 
 
Subsequent recent comparative analysis carried out using Illumina reads (the methodology is 
described in paper III) from these species against the Sylvio X10/cl1 reference confirmed 
the stable nature of the core genome in these species, but a low mappability rate in the 
subtelomeric regions, which indicates that these regions have a more rapid rate of evolution 
than the core genome. Similar characteristics have been noticed in fungi, where genomic 
areas containing genes coding for virulence factors have a more rapid evolutionary rate 
compared to regions containing housekeeping genes, to the point of rendering them sample 
specific 176–178. Large genomic rearrangements were observed across the entire genome of 
these two protozoans when compared against the Sylvio X10/cl1 reference, including core 
regions, implying an active genomic restructuring process.   
In the case of MARK, interspersed duplications were observed in chromosomal regions rich 
in mucins and retrotransposons while tandem duplications occurred in smaller regions within 
tandem arrays of trans-sialidases, mucins and MASPs. Multiple InDels with a slight bias 
towards short insertions, between one and five nucleotides were observed in the subtelomeric 
regions of MARK, accompanied by high levels of sequence diversity (7.24 SNV/Kb) in these 
areas compared with the core regions (1.1 SNV/Kb) when using Sylvio X10/cl1 as a 
reference; which together confirms that the surface proteins of MARK are diverged from 
those of T. cruzi, in response to the adaptation to different niches. 
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For RANG, deletions ranging from one to four kilobases in the subtelomeric regions were the 
most common genomic rearrangement. Interestingly, segmental duplications of regions 
containing trans-sialidase and mucin tandem arrays that were observed in MARK were 
absent in the same regions for RANG. Additionally, large genomic inversions in the 
subtelomeres and core regions were present exclusively for RANG in chr4 and chr16. Unlike 
the InDels observed in the MARK genome, it was not possible to detect an insertion or 
deletion bias in RANG, which could suggest a different mechanism of recombination in these 
regions compared to MARK or T. cruzi. Another characteristic of RANG was the lower 
sequence diversity observed in the subtelomeres compared with that of MARK (3.4 
SNV/Kb). 
 
Figure 3: Comparative analysis of T. rangeli and T. cruzi marinkellei against chromosome 2 of the T. cruzi 
Sylvio X10/cl1 reference strain. The large grey box represents a large (> 200 Kb) duplication in chromosome 2 
for T. cruzi marinkellei. Green boxes represent retrotransposons, clear blue represent genes, red and dark blue 
segments represent SNV.    
 
In conclusion, the expanded comparative analysis of these two trypanosome species with T. 
cruzi emphasised the specialised role of the subtelomeric gene families in the adaptive 
evolution of the parasite to new niches. These gene families can be expanded or eroded from 
the genome depending on their adaptive role and the extant paralogs are used to develop new 
specialised function tailored to invade cells and evade the immune system of a given host.    
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2.2 Paper III: Genome analysis of the Trypanosoma cruzi TcI clade reveals 
mechanisms to generate antigenic diversity. 
 
In this study, using high coverage of third generation sequencing data, it was possible to 
reconstruct the complete genome sequence of a Trypanosoma cruzi TcI strain at the whole 
chromosome level, revealing the entire genomic architecture of the elusive subtelomeric 
regions of this protozoa for the first time. This new reference sequence and whole-genome 
data from 35 T. cruzi TcI isolates and clones from different regions of the American continent 
were used to identify mechanisms involved in antigenic diversity generation in the parasite.   
 
 
Figure 4: Genomic diversity of Panamanian T. cruzi DTU-I isolates from patients. A 505 Kb segment from 
chromosome 3 shows the levels of sequence diversity in subtelomeric areas coding for trans-sialidases (far left) 
and core regions (centre).   
 
2.2.1 The T. cruzi genome architecture:  
The genome of the T. cruzi Sylvio X10/cl1 reference isolate contains a large amount of 
retrotransposons (3.06 Mbp) and microsatellites (1.4 Mbp) interspersed throughout the 
genome, but with a significantly higher density in subtelomeric regions. Previous estimates of 
repetitive content - using second generation sequencing data - were much lower 169, most 
likely due to the inability of genome assemblers to reconstruct these complex areas using 
second generation data29. The subtelomeric gene families are structured in tandem arrays 
consisting of two to three complete gene copies and a variable number of pseudogenes 
separated by microsatellite segments of variable length. Retrotransposons of the VIPER and 
R1 class were observed within or surrounding the tandem gene arrays. The presence of 
retrotransposons close to surface molecule genes and their pseudogenes generated the 
hypothesis that these elements are involved in the generation of new sequence variants. One 
  30 
possible mechanism for this could be an RNA-guided DNA insertion mechanism 179, as has 
been reported in other eukaryotes 180. However, other types of data, such as RNA-Seq are 
required to confirm this. 
 
2.2.2 Mechanisms for antigenic diversity generation: 
By studying the pattern of InDels and genomic rearrangements between TcI strains in the 
subtelomeric regions we identified two possible mechanisms to give rise to new sequence 
variants in the surface molecule repertoire. These mechanisms appear to be linked to the 
genomic architecture of the subtelomeres. 
 
The analysis of InDels in the 35 DTU-I isolates revealed a strong bias towards one to three 
nucleotide insertions in genomic segments rich in microsatellites and retrotransposons, a bias 
that has been previously associated with recombination hotspots 181,182 and gene conversion 
183,184. These InDels were found within microsatellites containing tandem repeats with motifs 
such as n(A), n(AT) and n(AG) or within the LTR region of VIPER retrotransposons. The 
microsatellites and retrotransposons provide a source of homology that can be exploited by a 
double strand break (DSB) mechanism for recombination that in turn can generate sequence 
diversity 185–187. 
 
The microhomology provided by LTRs and microsatellites suggests two possible 
mechanisms: Non-Allelic Homologous Recombination (NAHR)188 and Microhomology-
Mediated End Joining (MMEJ)189. MMEJ has been observed in T. brucei in the presence of 
sequence repeats 190 and a recent study, which applied CRISPR-Cas9 to T. cruzi, revealed 
signatures of DSB repair by MMEJ 191. On the other hand, NAHR has been associated with 
retrotransposons in higher eukaryotes 192 and the generation of de novo structural changes 
during meiosis 193, which has not been reported in T. cruzi but in other protozoans 194.  
 
Subsequently, we analysed genomic rearrangements in the 35 DTU-I genomes to identify 
actual recombination events in subtelomeric regions. In paper III we have identified large 
structural variants such as deletions, tandem and interspersed duplications, genomic 
inversions larger than ten kilobases, as well as translocation-associated break ends occurring 
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in subtelomeric regions in T. cruzi. These types of large genomic events have been associated 
with NAHR 195 but this is not the only possible mechanism, since NHEJ has also been linked 
to the generation of sequence translocations in AT-rich areas in humans, but at a much lower 
frequency than NAHR 196. The breakpoints of the interchromosomal rearrangements were 
detected using an improved mapping strategy and a consensus of different methods to detect 
genomic rearrangements (See paper III). The breakpoints were frequently located within the 
coding sequences of surface molecules genes, short microsatellite segments and LTRs of 
VIPER retrotransposons.   
 
Copy Number Variation (CNV) analysis in these isolates revealed a dynamic pattern of 
expansion and contraction of surface molecule gene family gene clusters. These were unique 
to each isolate regardless of their geographic origin or sample source, e.g: isolated from 
vectors or humans. Based on the results of the interchromosomal breakpoint mapping, it 
could be assumed that these expansions and contractions of specific gene families are the 
result of active intra- and inter-chromosomal reshuffling of subtelomeric segments for 
adaptive purposes, similar to what has been observed in certain fungi 176, which may be 
retrotransposon-driven 178,197.  
 
 
 
Figure 5: Copy Number Variation (CNV) profile of chromosome 2 of a DTU-I isolate from Ecuador. The blue 
line represents the reference sequence. Each black dot depicts a coverage sliding window. The red line represents 
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the sample genome in comparison with the reference. The X-axis represents the position in the chromosome in 
base-pairs; the y-axis represents fold-change.  
 
2.2.3 The population genetics of the T. cruzi TcI clade:  
WGS data from 35 T. cruzi DTU-I isolates from different geographic locations of the 
American continent was used to study the genomic diversity of this clade. A PCA analysis 
using InDels revealed that these isolates mostly formed well defined clusters based on their 
geographic location, a pattern that may be a reflection of adaption to the specific environment 
and selective pressure, similar to that observed in many other parasitic species 198,199. Linkage 
Disequilibrium (LD) was scanned genome-wide using the r2 statistic, which revealed that 
subtelomeric regions exhibit r2 values close to zero while core regions had values close to 
one 200. The lower r2 values and the patterns of balancing selection observed in the 
subtelomeric regions indicate that gene the families in these areas evolve rapidly, while the 
core genome changes more slowly, implying a genomic duality similar to the one observed in 
certain fungi 177,201. 
 
Figure 6: TcI linkage disequilibrium r2 matrix for chromosome 16. X-axis represents the number of markers; y-
axis represent the number of 10 Kb sliding windows. The r2 values close to 0 indicate recombination, while r2 
values close to 1 indicate clonality.  
 
Multiple diverse genotypes, reflected in the patterns of positive Tajima’s D, were observed in 
the subtelomeric gene families in parasites from different geographic locations. Samples 
isolated from vectors showed high levels of balancing selection in the subtelomeric regions 
whereas parasites isolated from mammalian hosts showed signatures of selective sweeps in 
the same regions. The balancing selection observed among Colombian clones derived from 
the same primary isolate, indicated that the parasite is constantly generating sequence 
diversity in the subtelomeres. The average Fst value for samples isolated from vectors was 
Fst = ~ 0.12 whereas for human isolates it was Fst = ~ -0.05 suggesting little to moderate 
genetic differentiation, respectively 202.  
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Figure 7: Distribution of Tajima’s D in 10 Kb sliding windows for chromosome 10 in Panama samples, where 
a) represents isolates derived from human patients and b) represents isolates derived from vectors. Red areas 
show values with negative Tajima’s D values (i.e: selective sweeps) and cerulean areas indicate positive 
Tajima’s D values (i.e: balancing selection). 
 
In conclusion, these data indicate that T. cruzi generates new antigenic variants via an active 
process of subtelomeric recombination - possibly mediated by MMEJ - while the core 
genome remains evolutionarily stable. Balancing selection in subtelomeric regions has 
resulted high levels of polymorphism for the surface protein gene families present in these 
areas. New alleles in these genes may confer an adaptive advantage 203, since they can be 
exploited by the parasite for immune evasion or rapid adaptation to the immune system of a 
new host, as reported in other eukaryotes 204.  
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2.3 Paper IV: Comparative genomic analyses of Trypanosoma cruzi 
experimental hybrids reveal mechanisms of genetic exchange.   
 
The identification of hybrid parasitic strains and genetic exchange is of great public health 
importance for the control of Chagas disease and the development of new drug targets 205.  
Earlier studies using biochemical 206 and single-locus molecular markers 207 suggested that 
Trypanosoma cruzi has a clonal population structure. However, more recent studies using 
molecular markers and genome sequencing (ref) as well as the formation of hybrids in vitro 
have shown that genetic exchange occurs in T. cruzi 150. These finding were later 
corroborated in multiple isolates 151, which led to the restructuring of the T. cruzi population 
history 146. In paper IV we extended the original analysis of in vitro hybrid strains using high 
coverage, whole genome sequencing of the parental and hybrid strains at different time-
points.    
 
2.3.1 Genome analysis of the parent strains: 
Two IPE libraries and a single IMP library with an average insert size of eight kilobases from 
both parental strains were sequenced at a total coverage depth of 140 X per each sample. 
These data were used to create de novo assemblies of the two parental strains for comparative 
purposes. Despite the high sequence coverage and the long-insert library, the repetitive nature 
of the T. cruzi genome made it impossible to completely reconstruct these genomes. As 
mentioned earlier, it is clear that either high coverage of single molecule long reads, or 
multiple data sets are needed to decipher the repetitive regions of the T. cruzi genome 
171,208,209. We were able to completely assemble the core regions, where most of the 
housekeeping genes are located, and to evaluate the conservation of core gene synteny 
between the parent strains and our TcI reference sequence, as previously described 210,211. The 
synteny was found to be well conserved, which is in agreement with previous analyses of TcI 
strains. Since the parental assemblies did not cover the entire genomes, we decided to 
proceed with the comparative analysis using the sequencing reads and taking advantage of 
the newly assembled and closely related Sylvio X10/1 reference genome. 
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Figure 8: Synteny in the core regions between the parental strains PI-0 and PII-0 and the Sylvio X10/cl1 
reference genome. Each coloured block represents a syntenic block in each sample. It can be noted that some 
blocks have been expanded in the parental strains (clear green and plum) or missing (dark blue).  
 
A systematic analysis of genomic variation in the parental strains showed that the vast 
majority of the sequence and structural changes were limited to the subtelomeric regions, 
which is in agreement with the analyses of other T. cruzi TcI strains (See paper III). Multiple 
genome rearrangements were detected and the most common were sequence break-ends 
similar to the unbalanced translocations observed in higher eukaryotes 212. Copy number 
variation (CNV) analyses showed that the subtelomeric regions, and certain loci in the core 
regions were expanded compared with the Sylvio X10/1 reference strain, and these 
expansions accounted for the higher repetitive content of the parents and this made it even 
more difficult to assemble the parent strains de novo. This observation also agrees with the 
variability of the genome size in T. cruzi field isolates from the same clade 153,213–215 as well 
as differences in the karyotype of isolates from the same clade 216,217.  
Interestingly, the subtelomeric gene families in the parental strains were found to have lost 
gene copies after 800 generations of growth in culture. The eroded regions contained genes 
involved in cell invasion and immune system evasion such as trans-sialidases and mucins. 
This may indicate that T. cruzi evolves in culture by selecting for the removal of genes that 
are not necessary in this environment, to allocate resources to other pathways.This 
mechanism has been widely observed in other species 172,218. This observation has 
implications for future evolutionary studies of the T. cruzi surface molecule repertoire and 
requires further analysis and experimental follow-ups.     
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Figure 9: CNV evolution of a parental strain over time. PI-0 is the sample at the initial state, and PI-120 are 
isolates after 800 generations. Each black dot depicts a coverage sliding window. The red line represents the 
sample genome in comparison with the reference. X-axis represents the position in the chromosome in base-
pairs; y-axis represents fold-change.  
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2.3.2 Genome analysis of the hybrid strains:  
Strain-specific genomic variants, such as SNPs and InDels, were identified in the parental 
clones to make it possible to identify parent-specific genetic material in the hybrid offspring. 
We compared the reads from the hybrid genomes against the T. cruzi Sylvio X10/cl1 
reference and detected parent-specific signatures distributed throughout the genome as well 
as new mutations. Parent-specific genomic blocks in the hybrid isolates were surrounded by 
short InDels, principally insertions ranging in size between one and five nucleotides, found 
within long stretches of simple repeats in intergenic regions and within the LTR segments of 
VIPER retrotransposons. As expected, the hybrid strains had a higher level of polymorphism 
in both housekeeping and surface molecule genes compared to the parental strains, due to the 
presence of both parental haplotypes for much of the genome . It is tempting to speculate that 
these genomic signatures are the result of microsatellite instability associated with defective 
DNA mismatch repair 219 and recombination associated with cell division 220–222. While the 
meiotic machinery has been described in T. cruzi and other protozoan parasites 194  and, 
although the presence of gametes has been reported in other kinetoplastids 223, there is no 
experimental evidence of gametes in T. cruzi. It is therefore still more likely that the 
recombination occurs during mitosis. 
  
 
Figure 10: a) Patterns of parent-specific genomic material in a hybrid. b) CNV in a trans-sialidase tandem array 
of a hybrid strain (red lines) compared with the reference (blue line). c) InDels (red and blue bars) around 
breakpoints (grey bars) in the hybrid offspring. Red blocks show genes and green blocks show retrotransposons.  
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By analysing the sequence coverage distribution and the pattern of structural changes in the 
hybrid offspring, it was possible to identify, almost entirely subtelomeric, regions that were 
expanded or eroded after the hybridisation event. These sequence expansions increased the 
genome sizes of the hybrids between 34.1% and 48.6 % compared to the parents, which 
seems to be why hybrid strains, such as TcVI CL Brener have larger subtelomeres 10, 
compared to non-hybrid strains such as TcI Sylvio X10/1169. It is currently unclear whether 
the expansion occurs through a 4n hybrid intermediate or through a different mechanism. The 
extensive expansion of surface molecule genes and the genomic rearrangements observed in 
these samples are very similar to the ones observed in pathogenic fungi, where they have 
been associated with increased virulence 176. It is possible to hypothesise that the combination 
of new surface molecule genes from both parents provides the hybrid strains with a pool of 
new sequences as substrates for the MMEJ-like recombination mechanism, as observed in 
other TcI strains, to create new antigenic variants in order to increase the potential for 
forming viable hybrid offspring (See paper III). After 800 generations of growth in culture, 
the hybrid genomes showed a similar pattern of genome erosion as in the parent strains. 
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CHAPTER 3 – FUTURE PERSPECTIVES 
 
Unlike other protozoan parasites, such Plasmodium falciparum and Trypanosoma brucei, the 
lack of a complete reference sequence has hampered the implementation of post-genomic 
studies in Trypanosoma cruzi.  
The present work describes the complete genome assembly and analysis of a T. cruzi TcI 
strain, furnishing the parasitology research community with a valuable resource to better 
understand the biological aspects of Chagas disease. The new reference sequence will serve 
as the scaffold for the implementation of large scale population genomic studies, gene 
expression analysis in different stages of the parasite life cycle, the characterisation of 
transcription dynamics of the parasite virulence factors, just to mention a few.  
In this work, using this genome sequence and an integrative genomic data analysis approach, 
it was possible to characterise a retrotransposon-driven mechanism that could be involved in 
the generation of antigenic variation in T. cruzi which could potentially be targeted with 
chemotherapeutic agents. However, this is just a small step in the application of post-genomic 
methods quest for new therapeutic interventions for Chagas disease and new analytical 
strategies should be implemented.    
There is an urgent need for the discovery of new, more effective drug targets and vaccine 
candidates for Chagas disease and other parasitic malaises, but the identification of those, 
with the current methodologies, is an expensive and time-consuming process 224. Genomic 
approaches have opened a new way to analyse complete gene families of protozoan genomes 
and their potential interaction with the host, providing a new alternative to identify drug 
targets and vaccine candidates more efficiently and cost effective.  
Omics datasets - composed by genomics, transcriptomics, proteomics, among others - 
provide an attractive source of biological information for different pathogenic organisms 
stored in public databases, such as the NCBI Short Reads Archive (SRA) 225. Some initiatives 
are already planning to use large public and private genomic datasets to identify links 
between genes and diseases in a  personalised way 226.  These large datasets could be mined 
with the latest data analytics 227,228 for the identification of vaccine candidates, new drug 
targets and the synergy between these molecules and the human host, in a cheaper, faster and 
effective way.      
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